Patients Drop MS Drug, Face Relapse Risk – MedPage Today
Patients Drop MS Drug, Face Relapse RiskMedPage TodayOf the nine patients who switched away from natalizumab, seven chose injectable drugs including interferon-beta products, glatiramer acetate (Copaxone), or rituximab (Rituxan). Two chose the oral dru…